|Bid||0.00 x 2200|
|Ask||0.00 x 1000|
|Day's Range||86.86 - 91.53|
|52 Week Range||77.01 - 181.83|
|Beta (5Y Monthly)||1.76|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 04, 2021 - May 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||129.00|
Sarepta (SRPT) Q4 revenues increase year over year. The company is progressing well with its pipeline.
Sarepta Therapeutics stock fell as markets digested its bigger-than-expected quarterly loss. But analysts say the setup for the stock remains positive.
SRPT earnings call for the period ending December 31, 2020.